Analytical Data
-
Gene name
TESK2
- Application
-
Alternative Names
Testicular protein kinase 2; Dual specificity testis-specific protein kinase 2
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8VCT9
-
Expression Region
Asp58~Met313
-
Molecular Weight
33kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TESK2, or TGF-beta-activated kinase 1, is a serine/threonine kinase that plays a significant role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its involvement in key signaling pathways, especially those related to transforming growth factor-beta (TGF-β) and mitogen-activated protein kinase (MAPK), has garnered attention in research for its implications in cancer biology and development. Abnormal expression or activity of TESK2 has been associated with various malignancies, making it a potential target for therapeutic intervention. Recent studies have focused on the structure and function of the TESK2 protein, aiming to elucidate its mechanism of action and role in tumor progression. Understanding the regulation of TESK2 and its interaction with other signaling molecules could provide insights into novel cancer treatment strategies. Moreover, the development of recombinant TESK2 protein allows for detailed biochemical and structural analyses, enhancing our comprehension of its function and potentially leading to the identification of new biomarkers or therapeutic targets in cancer treatment and regenerative medicine. As research continues to unfold, the characterization of TESK2's role in cellular signaling and its implications in disease pathology will be pivotal for advancing our understanding of tumor biology and for developing innovative therapeutic approaches.
